Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Long-Term Investments (2018 - 2025)

Mesoblast's (MEOBF) quarterly Long-Term Investments came in at $1.6 million in Q4 2025, up 28.39% year-over-year from $1.2 million in Q4 2024, and up 11.74% quarter-over-quarter from $1.4 million in Q2 2025.

Analysis

Mesoblast (MEOBF) Long-Term Investments (2018 - 2025) Analysis & Trends

Mesoblast has disclosed Long-Term Investments across 8 years of filings, most recently posting $1.6 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 28.39% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 28.39% YoY), while the FY2025 annual figure was $1.4 million, up 36.88% from the prior year.
  • Long-Term Investments came in at $1.6 million for Q4 2025 at Mesoblast, up from $1.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.3 million in Q4 2021 to a low of $826000.0 in Q4 2023.
  • Average Long-Term Investments over 5 years is $1.7 million, with a median of $1.8 million recorded in 2022.
  • Year-over-year, Long-Term Investments slumped 57.62% in 2023 and surged 46.25% in 2024.
  • Over 5 years, Long-Term Investments stood at $2.3 million in 2021, then decreased by 16.96% to $1.9 million in 2022, then tumbled by 57.62% to $826000.0 in 2023, then jumped by 46.25% to $1.2 million in 2024, then rose by 28.39% to $1.6 million in 2025.
  • Per Business Quant data, the three most recent Long-Term Investments figures were $1.6 million in Q4 2025, $1.4 million in Q2 2025, and $1.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 257.29 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 30.27 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 490,000.00
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 362.70 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 102.10 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Jun 30, 2025 1.39 Mn
Dec 31, 2024 1.21 Mn
Jun 30, 2024 1.01 Mn
Dec 31, 2023 826,000.00
Jun 30, 2023 1.76 Mn
Mar 31, 2023 2.03 Mn
Dec 31, 2022 1.95 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 1.76 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.35 Mn
Sep 30, 2021 2.23 Mn
Jun 30, 2021 2.08 Mn
Mar 31, 2021 1.98 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 1.95 Mn
Jun 30, 2020 1.87 Mn
Mar 31, 2020 1.77 Mn
Dec 31, 2019 1.67 Mn